Print

Entelos, Inc. and RegeneMed Introduce iToxFX to Help Predict the Safety of New Drugs  
3/8/2010 9:24:40 AM

FOSTER CITY, Calif. & SAN DIEGO--(BUSINESS WIRE)--Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
//-->